Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes

ReachMD CME
31/03/2025 5 min

Listen "Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes "

Descargar episodio Ver en sitio original

Episode Synopsis

CME credits: 1.00
Valid until: 02-12-2026
Claim your CME credit at https://reachmd.com/programs/cme/ProactiveAdverseEffectManagementinmCRCImprovingTolerabilitytoOptimizePatientOutcomes/32945/



This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.

More episodes of the podcast ReachMD CME

Hepatic Encephalopathy: More Common Than You Think 11/12/2025
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies 26/11/2025
The Fifth Pillar? Closing the Gap in HFrEF 14/11/2025
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach 13/11/2025
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need 11/11/2025
Updates in Major Depressive Disorder with Insomnia 07/11/2025
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD 31/10/2025
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia 30/10/2025
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology 29/10/2025
Hepatic Encephalopathy: An Ominous Sign 23/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA